- Home
- IKT vs SKIN Comparison
IKT vs SKIN Comparison
Compare IKT & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IKT | SKIN |
|---|---|---|
| Founded | 2008 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.9M | 202.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | IKT | SKIN |
|---|---|---|
| Price | $1.54 | $1.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $4.00 | $2.42 |
| AVG Volume (30 Days) | 428.3K | ★ 786.8K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $301,917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.33 | $0.78 |
| 52 Week High | $4.20 | $2.69 |
Technical Indicators
Market Signals| Indicator | IKT | SKIN |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 47.46 |
| Support Level | $1.43 | $1.42 |
| Resistance Level | $1.57 | $1.57 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 73.81 | 35.14 |
Price Performance
Historical ComparisonAbout IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.